BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vaccinex, Inc. 

1895 Mt. Hope Avenue

Rochester  New York  14620  U.S.A.
Phone: 585-271-2700 Fax: 585-271-2766


SEARCH JOBS




Industry
Biotechnology






 Company News
Vaccinex, Inc. Announces Initiation of a Phase 1 Clinical Trial of VX15/2503 Antibody in Multiple Sclerosis Patients 1/7/2013 11:20:09 AM
Vaccinex, Inc. Initiates Phase I Clinical Trial of Novel Therapeutic Antibody in Cancer Patients With Advanced Solid Tumors 1/4/2011 6:21:48 AM
Vaccinex, Inc. Awarded Three Qualifying Therapeutic Discovery Project (QTDP) Grants Under the Patient Protection and Affordable Care Act of 2010 (PPACA) 11/2/2010 7:00:09 AM
John E. Leonard, Ph.D. Joins the Scientific Advisory Board of Vaccinex, Inc. 3/5/2008 10:44:49 AM
Vaccinex, Inc. Antibody Licensed to GlaxoSmithKline (GSK) 2/15/2008 1:47:41 PM
Vaccinex, Inc. Announces Award of Key Patent in Europe for its Antibody Discovery Technology (ActivMab(R)) 11/30/2007 9:51:24 AM
Vaccinex, Inc. Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology 2/27/2007 11:13:55 AM
OPi, SAS And Vaccinex, Inc. Announce License Of Fully Human Anti-IL6 Antibody 10/10/2006 10:56:40 AM
Vaccinex, Inc. To Present At Antibody World Summit 5/23/2006 5:08:51 PM
Vaccinex, Inc. Announces Antibody Collaboration With Schering AG (SHR) 2/10/2006 10:18:08 AM
12